Rare or 'orphan' diseases include nearly 7000 disorders and affect 2-3 million Canadians. For children with rare diseases, standard medical approaches often do not meet their needs, necessitating further research. However, research precedent often does not exist for rare diseases and never exists for uncharacterized diseases. Thus, the traditional research funding paradigm, which requires precedent and evidence of prior funding in an area of expertise, is unsuitable to fund research into rare or uncharacterized diseases.
The Rare Disease Foundation has recognized this problem and identified a new model for improving care of patients with rare disorders. For patients with rare conditions, research IS care. To this end, the Rare Disease Foundation, in collaboration with BCCHF, and Global Genes, provides microgrants to expedite exploration of new ideas for understanding rare diseases and improving patient care. Click here to see summaries and videos about our funded projects. Awards of up to CAD$3500 will be available, one investigator may apply for multiple awards and awards will be in effect for a maximum of 1 year from project start date. Please ask only for what you need to complete the proposed studies as our funds are limited. Travel expenses to conferences or publication costs will not be covered but technical services or salaries, reagents, etc. will be. No overhead is paid with a microgrant. If successful, applicants may also request the services of a grant writer to assist with subsequent grant submission.
- involve a rare disease or rare subtype of disease (lifetime prevalence < 1 in 2000)
- directly impact patient care for one or more patients
- scientifically valid and feasible
- ethics approval (microgrant activation requires an ethics approval certificate, where applicable)
Applications may be submitted by anyone (faculty, staff, or student) as long as they have a supervisor or collaborator who can receive the funds and is associated with a Registered Institution listed here, or with any Canadian institution. Research proposals must not exceed 1 page (11 pt font size, 0.75 inch margins), must indicate how this study will improve care, include a scientific summary containing background, hypothesis, methods and brief budget justification sections, and include a lay summary addressing a non-medical, non-scientific audience. Please submit proposals by November 1, 2016 at this link. Decision letters will be emailed within 15 business days.
Applications will be de-identified and reviewed by both the scientific and parent (lay) advisory boards of the Rare Disease Foundation for their impact on care, scientific validity and for their adherence to the priorities of patients and their families. Successful applicants are expected to provide a 1 paragraph lay summary describing their results upon project completion and describe how their work improved patient care. Lay summaries will be posted on our website after funding decisions are made so please do not include any proprietary, patient-identifying or confidential information in your lay summary. Patients and their families must not be specifically identifiable to someone familiar with their situation. Scientific summaries are kept confidential and are only seen by reviewers. Funded projects are expected to lead to dissemination of results through publication or meeting presentation, and/or generate preliminary data for larger studies directed at improving patient care. If funding is readily available elsewhere, the rationale for requesting it from this program should be provided. We request that publications containing data supported by microgrants acknowledge the support of the Rare Disease Foundation and BC Children's Hospital Foundation.
For program enquires please contact the Program Coordinator, Dr. Kerstin Mueller at: research at rarediseasefoundation.org or the Research Director, Dr. Millan Patel at: mpatel at cw.bc.ca. For website submission difficulties, please contact our Technology Director: Sohail at rarediseasefoundation.org